Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2010
12/01/2010CN101899049A Disubstituted pyrazolobenzodiazepines
12/01/2010CN101107252B Tetrahydrofurane derivatives for use as inhibitors of matrix metalloproteinases
11/2010
11/30/2010US7842808 Anti-migraine spirocycles
11/30/2010US7842802 Vinorelbine derivatives
11/30/2010US7842687 Cephalotaxane derivatives and their processes of preparation and purification
11/30/2010CA2497868C Heterocyclic compounds
11/25/2010WO2010135560A1 Modulators of 5-ht receptors and methods of use thereof
11/25/2010WO2010133337A1 Herbicidal spiroheterocyclic tetronic acid derivatives
11/25/2010WO2010088050A3 Bicyclic pyrazolo-heterocycles
11/25/2010WO2010081034A3 Fluorine containing compounds and methods of use thereof
11/25/2010WO2010080817A3 Carbohydrate-cyclopamine conjugates as anticancer agents
11/25/2010US20100298557 Pyrazolopyrimidine compound
11/25/2010US20100298369 Berbamine derivatives
11/25/2010US20100298331 Triazinone and diazinone derivatives useful as hsp90 inhibitors
11/25/2010US20100298292 Modulators of 5-ht receptors and methods of use thereof
11/25/2010US20100298291 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2010US20100298288 Cetp inhibitors derived from benzoxazole arylamides
11/25/2010US20100298145 Spiroheterocyclic Tetronic Acid Derivatives
11/25/2010US20100297046 Compositions and Methods Related to Fructosamine-3-Kinase Inhibitors
11/25/2010CA2761961A1 Modulators of 5-ht receptors and methods of use thereof
11/24/2010EP2253639A1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
11/24/2010EP2253635A1 Novel hydrophilic and lipophilic rhodamines for labelling and imaging
11/24/2010EP2253620A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
11/24/2010EP1973878B1 Process and intermediate for preparation of donepezil
11/24/2010EP1549156B1 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it
11/24/2010CN1925859B 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy
11/24/2010CN101896490A Trisubstituted piperidines as renin inhibitors
11/24/2010CN101894912A Electric conductivity adjustable organic molecular film and semiconductor hybrid material and preparation method thereof
11/24/2010CN101892181A Streptoseomycin and preparation method and application thereof
11/24/2010CN101891751A Method for preparing tetrodotoxin
11/24/2010CN101891750A Preparation method of stephanine and hydrochloride thereof
11/24/2010CN101891749A (1S, 2R, 5S)-6-(4-methoxyphenyl)-2-methyl-4, 7-dioxo-3-oxa-6-azabicyclo[3, 2, 0] heptane-5-carboxylate and preparation method thereof
11/24/2010CN101306613B Color imaging method
11/24/2010CN101195627B New application of benzo [C] phenanthridine and protopine in producing overriding resistant bacterium medicament
11/24/2010CN101137361B Potassium channel opener having benzofuroindole skeleton
11/23/2010US7838674 2-(1-amino-cyclobutylmethyl)-8-(4-methoxy-phenyl)-4,5-dihydro-1 H-1,7,9-triazacyclopenta[a]naph-thalene-3-carboxylic acid lactame; useful especially as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 (MK2 or MAPKAP kinase-2
11/23/2010US7838521 phosphodiesterase PDE4 inhibitor; preparing claimed 3-(dialkoxy)phenyl-4-aminopyran intermediate from the claimed 4-oxo compound starting with hydrobromination of the corresponding phenylacetylene; antiinflammatory for airways and skin; respiratory; bronchodilator
11/23/2010CA2599860C 1, 2, 4-triazole derivatives and their use as oxytocin antagonists
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/23/2010CA2342200C Use of certain drugs for treating nerve root injury
11/18/2010WO2010132570A1 Synthesis of morphine and related derivatives
11/18/2010WO2010132538A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
11/18/2010WO2010132352A2 Spiro compounds and their use as therapeutic agents
11/18/2010WO2010131145A1 Cyclobutenedione derivatives
11/18/2010WO2010130139A1 Ascorbic acid aryl acetate/propionate ester, preparation method and pharmaceutical composition thereof
11/18/2010WO2010130034A1 Inhibitors of human immunodeficiency virus replication
11/18/2010WO2010106457A3 3-oxa-7-azabicyclo[3.3.1]nonanes
11/18/2010WO2010067078A3 3,6-disubstituted xanthylium salts as medicaments
11/18/2010WO2010045251A3 Spiro-oxindole compounds and their use as therapeutic agents
11/18/2010US20100292266 Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase
11/18/2010US20100292247 Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
11/18/2010US20100292227 Inhibitors of human immunodeficiency virus replication
11/18/2010US20100292187 Methods for treating hepatitis c
11/18/2010CA2762036A1 Inhibitors of human immunodeficiency virus replication
11/18/2010CA2761287A1 Synthesis of morphine and related derivatives
11/18/2010CA2760205A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
11/17/2010EP2251327A2 Heterocyclic inhibitors of MEK and methods of use thereof
11/17/2010EP2250177A1 Luminescence quenchers and fluorogenic probes for detection of reactive species
11/17/2010EP2250176A1 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands
11/17/2010EP1931680B1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
11/17/2010EP1585522B1 Quinazolinones as potassium channel modulators
11/17/2010CN101889010A Isoxazolo-pyridine derivatives
11/17/2010CN101492452B Sulfhydryl benzimidazole derivative containing dioxepane-pyridine
11/17/2010CN101080231B Method for preparing galantamine hydrobromide
11/16/2010US7834177 Catalytic dehydrogenation with gaseous hydrogen of 11a,10b-dihydro-6H-dibenz/b,f/oxireno[d] azepine-6-carboxamide; anticonvulsant; chemical intermediate
11/16/2010US7834026 histone deacetylase inhibitors; antiproliferative; antineoplastic; thioredoxin (TRX)-mediated diseases such as autoimmune, allergy, inflammatory diseases; and neurodegenerative diseases; N-(2-Aminophenyl)-6-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)nicotinamide; hydroxamic acid moiety
11/16/2010US7833756 Methods of labelling polynucleotides with dibenzorhodamine dyes
11/16/2010CA2487329C Process for the manufacture of quinoline derivatives
11/11/2010WO2010128659A1 Diamino heterocyclic carboxamide compound
11/11/2010WO2010128425A1 Gpr 119 modulators
11/11/2010WO2010128414A1 Gpr 119 modulators
11/11/2010WO2010105179A3 Inhibitors of beta-secretase
11/11/2010US20100286396 Novel isoquinoline derivatives
11/11/2010US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
11/11/2010US20100286181 Pyrrole derivatives with antibacterial activity
11/11/2010US20100286164 Substituted aryl alkylamino-oxy-analogs and uses thereof
11/11/2010US20100284945 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy
11/11/2010CA2760061A1 Diamino heterocyclic carboxamide compound
11/11/2010CA2759891A1 Gpr 119 modulators
11/10/2010EP2247597A1 Fused heteroaryl modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
11/10/2010EP2146997B1 Substituted furo[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators
11/10/2010EP1995249B1 Camptothecin derivatives and their use
11/10/2010EP1742944B1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
11/10/2010CN1984900B Indole derivatives having piperidine rings
11/10/2010CN101883762A Benzothiazoles as ghrelin receptor modulators
11/10/2010CN101880285A Method for synthetizing allyl-substituted camptothecin compound
11/10/2010CN101880284A Chemical synthesis method of Epothilone B-lactam derivative
11/10/2010CN101880277A Aza spiro alkane derivatives as inhibitors of metallproteases
11/10/2010CN101880276A Substituted diazepan compounds as orexin receptor antagonists
11/10/2010CN101171249B Method for producing indole derivative having piperidine ring
11/10/2010CN101085041B Total alkaloid of lotus leaves extraction and its preparation method
11/10/2010CA2759843A1 Gpr 119 modulators
11/09/2010US7829570 Substituted 4-amino isoxazolo[5,4-d]pyrimidines as kinase inhibitors
11/04/2010WO2010127363A1 Toposiomerase inhibitors
11/04/2010WO2010127360A1 Toposiomerase inhibitors
11/04/2010WO2010126138A1 Novel crystal forms of tricyclic benzopyran compound and processes for producing same
11/04/2010WO2010126082A1 Therapeutic agent for motor disorders
11/04/2010WO2010126025A1 Quaternary ammonium salt compound
11/04/2010WO2010125985A1 Fused heterocyclic compound and use thereof
11/04/2010WO2010125811A1 Carbinol compound having heterocyclic linker
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 298